Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Powell Michael
Relationship:   10% Owner
City:   San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   21    
Direct Shares   22,645,475    

Indirect Shares

   6,181,468      
Direct Value   $15,394,877    

Indirect Value

   $148,318,714      
Total Shares   28,826,943      
Total Value   $163,713,592      


Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $41 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,312,375 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,582,203 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $2,093,372 Vera Therapeutics, Inc. $0 Seagen Inc $4,575,029 Molecular Templates, Inc. $2,064,809 Anesiva Inc $0 Paratek Pharmaceuticals Inc $96,365 Humanigen Inc $41 Aravive Inc $86,094 Aclaris Therapeutics, Inc. $2,312,375 Entasis Therapeutics Holdings Inc. $2,584,590 Nextcure, Inc. $0 Iterum Therapeutics Plc $1,582,203 Akouos, Inc. $0 Inozyme Pharma, Inc. $0 Bolt Biotherapeutics, Inc. $2,093,372 Vera Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    2    

     Stock price went up :
    0   
    2    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   2.0   
     Percentage Gain/Loss :
   -63.7%
 32.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Seagen Inc SGEN Director 2004-12-16 20,001 2004-12-16 647,577    Premium*  
            Molecular Templates, Inc. MTEM Director 2005-03-08 3,440,201 2006-03-16 12,846    Premium*  
            Anesiva Inc ANSVQ Director, 10% Owner 2007-12-18 65 2007-12-18 4,906,973    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-09 43,213 0    Premium*  
            Orexigen Therapeutics, Inc. OREX Director 2010-12-23 1 2010-12-23 0    Premium*  
            Trius Therapeutics Inc TSRX Director 2010-08-06 0 2012-03-26 9,302    Premium*  
            Humanigen Inc HGEN 10% Owner 2013-02-05 414,394 2013-02-05 0    Premium*  
            Ocera Therapeutics Inc OCRX Director 2016-07-29 0 2016-10-31 14,328    Premium*  
            Aravive Inc ARAV 10% Owner 2014-03-26 2,146,978 2014-03-26 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 2015-05-07 0 2014-06-04 0    Premium*  
            Aerie Pharmaceuticals Inc AERI 10% Owner 2014-07-10 0 2014-07-09 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS 10% Owner 2014-08-05 0 2016-10-20 15,470    Premium*  
            Synlogic Inc SYBX Director 2015-10-05 0 2018-01-26 574,972    Premium*  
            Aclaris Therapeutics, Inc. ACRS 10% Owner 2015-10-13 2,289,480 2015-10-13 0    Premium*  
            Entasis Therapeutics Holdings Inc. ETTX 10% Owner 2018-09-28 1,180,178 2018-09-28 0    Premium*  
            Nextcure, Inc. NXTC 10% Owner 2019-11-15 2,671,856 2019-11-15 0    Premium*  
            Iterum Therapeutics Plc ITRM 10% Owner 2020-06-02 1,226,514 2020-06-01 0    Premium*  
            Akouos, Inc. AKUS 10% Owner 2020-06-30 1,515,073 2020-06-30 0    Premium*  
            Inozyme Pharma, Inc. INZY 10% Owner 2020-07-28 2,028,308 2020-07-28 0    Premium*  
            Bolt Biotherapeutics, Inc. BOLT 10% Owner 2021-02-09 2,754,437 2021-02-09 0    Premium*  
            Vera Therapeutics, Inc. VERA 10% Owner 2021-05-18 2,914,776 2021-05-18 0    Premium*  
* Premium Members only  

Records found :    126         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
OREX Orexigen Therapeutics, In... Director   –       •      –    2010-12-21 4 S $8.38 $3,145,116 I/I (375,339) 5,101 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2010-12-20 4 S $8.50 $2,763,995 I/I (325,000) 9,305 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2010-12-17 4 S $8.76 $1,149,575 I/I (131,254) 12,945 0 -
SGEN Seagen Inc Director   –       •      –    2003-12-30 4 S $8.90 $62,300 I/I (7,000) 1,791,677 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2009-09-10 4 S $9.18 $3,670,000 I/I (400,000) 22,255 0 -
SYBX Synlogic Inc Director   –       •      –    2018-01-26 4 A $9.75 $1,462,500 I/I 150,000 574,972 0 -
SGEN Seagen Inc Director   –       •      –    2004-03-08 4 S $10.33 $521,988 I/I (50,000) 1,743,052 -
SGEN Seagen Inc Director   –       •      –    2004-03-09 4 S $10.35 $155,250 I/I (15,000) 1,728,464 -
ACRS Aclaris Therapeutics, Inc... 10% Owner   –       –       •   2015-10-13 4 B $11.00 $4,499,990 D/D 409,090 2,289,480 2.45 -
VERA Vera Therapeutics, Inc. 10% Owner   –       –       •   2021-05-18 4 B $11.00 $7,999,992 D/D 727,272 2,914,776 2.45 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-21 4 S $12.00 $63,600 I/I (5,300) 31,655 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-25 4 S $12.00 $57,612 I/I (4,800) 31,555 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-27 4 S $12.05 $241,040 I/I (20,000) 31,355 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-28 4 S $12.05 $130,091 I/I (10,800) 31,255 0 -
OREX Orexigen Therapeutics, In... Director   –       •      –    2008-08-29 4 S $12.09 $8,460 I/I (700) 454,748 0 -
MTEM Molecular Templates, Inc. Director   –       •      –    2006-03-16 4 S $14.25 $36,508,500 I/I (2,562,000) 12,846 -
ETTX Entasis Therapeutics Hold... 10% Owner   –       –       •   2018-09-28 4 B $15.00 $5,065,860 D/D 337,724 1,180,178 2.45 -
INZY Inozyme Pharma, Inc. 10% Owner   –       –       •   2020-07-28 4 B $16.00 $7,000,000 D/D 437,500 2,028,308 2.45 -
AKUS Akouos, Inc. 10% Owner   –       –       •   2020-06-30 4 B $17.00 $999,991 D/D 58,823 1,515,073 2.45 -
BOLT Bolt Biotherapeutics, Inc... 10% Owner   –       –       •   2021-02-09 4 B $20.00 $9,000,000 D/D 450,000 2,754,437 2.45 %
ARAV Aravive Inc 10% Owner   –       –       •   2014-03-26 4 B $21.00 $1,260,000 D/D 60,000 2,146,978 2.45 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-07-09 4 S $24.00 $24,001,300 D/D (1,000,000) 1,566,657 0 -
AERI Aerie Pharmaceuticals Inc 10% Owner   –       –       •   2014-07-10 4 S $25.81 $207,030 D/D (8,022) 0 0 -
HPTX Hyperion Therapeutics Inc 10% Owner   –       –       •   2014-06-04 4 S $27.70 $11,571,592 D/D (417,747) 1,939,474 0 -
NXTC Nextcure, Inc. 10% Owner   –       –       •   2019-11-15 4 B $36.75 $5,512,500 D/D 150,000 2,671,856 2.45 -
  126  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us